HK1043739A1 - Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa. - Google Patents

Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.

Info

Publication number
HK1043739A1
HK1043739A1 HK02105172A HK02105172A HK1043739A1 HK 1043739 A1 HK1043739 A1 HK 1043739A1 HK 02105172 A HK02105172 A HK 02105172A HK 02105172 A HK02105172 A HK 02105172A HK 1043739 A1 HK1043739 A1 HK 1043739A1
Authority
HK
Hong Kong
Prior art keywords
pharmaceutical composition
pathological conditions
protozoa
yeasts
fungi
Prior art date
Application number
HK02105172A
Inventor
Gudrun Claus-Herz
Christoph Kessler
Gunther Bellmann
Original Assignee
Mann Gerhard Chem Pharm Fab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mann Gerhard Chem Pharm Fab filed Critical Mann Gerhard Chem Pharm Fab
Publication of HK1043739A1 publication Critical patent/HK1043739A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

The invention relates to a pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and/or protozoa. The inventive composition is especially provided in the form of an aqueous solution, of a gel capable of dripping, of an ointment or the like. The invention also relates to the use of the pharmaceutical composition in order to produce a medicament for treating the pathological conditions caused by the aforementioned pathogens. The invention additionally relates to the use of the pharmaceutically active substances for producing ophthalmic compositions.
HK02105172A 1999-04-22 2002-07-12 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa. HK1043739A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19918324A DE19918324A1 (en) 1999-04-22 1999-04-22 Bactericidal, virucidal, fungicidal and antiprotozoal pharmaceutical composition, especially for ophthalmological use, contains benzalkonium salt
PCT/EP2000/000191 WO2000064429A1 (en) 1999-04-22 2000-01-13 Pharmaceutical composition effective against pathological conditions caused by bacteria, viruses, fungi, yeasts and protozoa

Publications (1)

Publication Number Publication Date
HK1043739A1 true HK1043739A1 (en) 2002-09-27

Family

ID=7905524

Family Applications (1)

Application Number Title Priority Date Filing Date
HK02105172A HK1043739A1 (en) 1999-04-22 2002-07-12 Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.

Country Status (8)

Country Link
EP (1) EP1171107B1 (en)
AT (1) ATE284209T1 (en)
AU (1) AU2904700A (en)
DE (2) DE19918324A1 (en)
ES (1) ES2234569T3 (en)
HK (1) HK1043739A1 (en)
PT (1) PT1171107E (en)
WO (1) WO2000064429A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7767216B2 (en) 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
WO2006110699A1 (en) * 2005-04-11 2006-10-19 Nanobio Corporation Quaternary ammonium halides for treatment of infectious conditions
DE102006010643A1 (en) * 2006-03-08 2007-09-13 Bayer Healthcare Aktiengesellschaft Using quaternary ammonium compounds to inhibit precipitation of fluoroquinolone antibiotics, particularly in ready-for-use formulations for veterinary medicine
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
CA3107304A1 (en) * 2018-07-24 2020-01-30 Carefusion 213, Llc Ready-to-use, terminally sterile packaging for surgical antiseptic and method of use

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU499860B2 (en) * 1975-04-24 1979-05-03 Honda Giken Kogyo Kabushiki Kaisha Deflector plate to equalise fuel distribution in induction gas flow
IT1082339B (en) * 1977-02-07 1985-05-21 Zambelletti Dr L Spa COMPOUND WITH DISINFECTANT ACTIVITY AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN IT
DE3528209C2 (en) * 1984-08-07 1993-10-28 Fresenius Ag disinfectant
FR2616065A1 (en) * 1987-06-02 1988-12-09 Pabst Jean Yves Quaternary ammonium-based pharmaceutical aerosol
DE3870111D1 (en) * 1987-09-11 1992-05-21 Syntex Inc PROTECTIVE AGENT FOR EYE PREPARATIONS.
FR2620698B1 (en) * 1987-09-23 1990-08-10 Atlantic Pharma Prod QUATERNARY AMMONIUM FLUORIDE AND ITS APPLICATION IN AN INHIBITOR OR DESTRUCTIVE SUBSTANCE OF SINGLE-CELL LIVING BEINGS
WO1994015597A1 (en) * 1993-01-11 1994-07-21 Allergan, Inc. Ophthalmic compositions comprising benzyllauryldimethylammonium chloride
FR2715300B1 (en) * 1994-01-24 1996-03-29 Aromafarm Ltd Benzalkonium fluoride solution for injection and application as an antiviral or anti-infective.
JPH0812572A (en) * 1994-07-01 1996-01-16 Kosakai:Kk Therapeutic agent for dermatomycosis
JP3987593B2 (en) * 1995-10-02 2007-10-10 サンスター株式会社 Oral composition containing sodium chloride and magnesium chloride
DE19614823A1 (en) * 1996-04-15 1997-10-16 Mann Gerhard Chem Pharm Fab Ophthalmic composition with prolonged retention time on the eye
JPH10130156A (en) * 1996-10-30 1998-05-19 Teika Seiyaku Kk Eye drop composition
US5994383A (en) * 1997-11-18 1999-11-30 Woodward Laboratories, Inc. Surfactant-based antimicrobial compositions and methods for using the same
DE19837549A1 (en) * 1998-08-19 2000-02-24 Beiersdorf Ag Use of quaternary nitrogen compounds for treatment and prevention of atopic eczema

Also Published As

Publication number Publication date
ATE284209T1 (en) 2004-12-15
EP1171107B1 (en) 2004-12-08
DE50008908D1 (en) 2005-01-13
EP1171107A1 (en) 2002-01-16
WO2000064429A1 (en) 2000-11-02
ES2234569T3 (en) 2005-07-01
AU2904700A (en) 2000-11-10
PT1171107E (en) 2005-03-31
DE19918324A1 (en) 2000-10-26

Similar Documents

Publication Publication Date Title
BG108443A (en) Substituted oxazoliidinones for combinational therapy
AU2878689A (en) Locally administrable 2-amino-3-benzoyl phenylacetic acid derivatives as therapeutic compositions for inflammatory disease
EA200200059A1 (en) COMBINATION OF MILK-ACID BACTERIA AND ITS APPLICATION FOR PREVENTION AND / OR TREATMENT OF INFECTIONS AND INFLAMMATORY CONDITIONS
NZ718955A (en) Compositions comprising povidone-iodine
AU766216C (en) Method for the treatment of cerebral ischaemia and use of erythropoietin or erythropoietin derivatives for the treatment of cerebral ischaemia
MXPA02005173A (en) Remedies for diseases in association with decrease in bone mass.
CA2388939A1 (en) Therapeutic treatments for blood cell deficiencies
MY159377A (en) Aqueous suspensions of ciclesonide for nebulisation
DE69417920T2 (en) USE BEFORE SIMPLE OR CONJUGATED DEXTRAN FOR THE PRODUCTION OF A MEDICINE FOR PREVENTING OR REDUCING THE RISK OF A BACTERIAL PATHOGENIC INFECTION
WO2000018387A3 (en) Antibiotic compositions for treatment of the eye, ear and nose
HK1043739A1 (en) Use of a pharmaceutical composition in the manufacture of a medicament for the treatment of pathological conditions of the eye caused by bacteria, viruses, fungi, yeasts and protozoa.
WO2002067971A3 (en) Use of endostatin in the treatment of ocular neovascularization
CA2529441A1 (en) Use of hyaluronic acid for preparing compositions for treating oral cavity aphthas
ATE321045T1 (en) METHODS AND COMPOSITIONS FOR TREATING PAIN
JO3448B1 (en) Use of azithromycin for the manufacture of a medicament intended for the treatment of ocular infections
WO2002076393A3 (en) Antiagionecic, antitumor, chemopreventative agents
HK1050203A1 (en) Novel fusidic acid derivatives.
BR0016720A (en) Use of trimebutin to treat pain
AU2002234644A1 (en) Use of 5-substituted nucleosides and/or prodrugs thereof in the resistance-free treatment of infectious diseases
AU2003294834A1 (en) Anthranilic acid amide derivatives and their pharmaceutical use
TW200701989A (en) Health care composition for oral cavity and manufacturing method thereof
PL369845A1 (en) Use of 4-oxobutanoic acid derivatives in the treatment of inflammation
UA37377A (en) Method for preparing ointment for treating diseases caused by intracellular infectious agents
KR20000061943A (en) Aaaaa
CN1133711A (en) Therapeutic sterilization medicine composition

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20200112